QUADRA: A Phase Ii, Open-Label, Single-Arm Study to Evaluate Niraparib in Patients (Pts) with Relapsed Ovarian Cancer (Roc) in 4Th or Later Line of Therapy: Results from the Tbrcamut Subset
AuthID
P-00V-TA3
P-00V-TA3